Renaissance Technologies LLC Sells 21,682 Shares of TRxADE HEALTH, Inc. (NASDAQ:MEDS)

Renaissance Technologies LLC reduced its stake in TRxADE HEALTH, Inc. (NASDAQ:MEDS) by 65.0% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 11,700 shares of the company’s stock after selling 21,682 shares during the quarter. Renaissance Technologies LLC owned approximately 0.83% of TRxADE HEALTH worth $131,000 at the end of the most recent reporting period.

Separately, Virtu Financial LLC acquired a new stake in shares of TRxADE HEALTH during the 1st quarter worth approximately $109,000. 5.68% of the stock is owned by hedge funds and other institutional investors.

TRxADE HEALTH Price Performance

Shares of TRxADE HEALTH stock opened at $7.59 on Monday. The company’s fifty day moving average price is $7.31 and its two-hundred day moving average price is $8.70. TRxADE HEALTH, Inc. has a 52-week low of $3.69 and a 52-week high of $44.56.

TRxADE HEALTH (NASDAQ:MEDS) last announced its earnings results on Friday, August 9th. The company reported ($1.04) earnings per share (EPS) for the quarter. The firm had revenue of $0.02 million for the quarter. TRxADE HEALTH had a negative return on equity of 196.79% and a negative net margin of 149.81%.

TRxADE HEALTH Company Profile

TRxADE HEALTH, Inc operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace.